Skip to content

GRCE

Grace Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.11
−0.94%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 12, 2026
EPS estimate
-$0.15
Revenue estimate
$1.0M

Latest reported

Last report date
Aug 13, 2026
EPS actual
-$0.91
EPS estimate
-$0.13
Revenue actual
Revenue estimate
$400.0K

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
7
EPS in line (12Q)
1
Avg surprise (4Q)
-153.4%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 13, 2026-$0.13-$0.91Miss -603.79%
Jun 18, 2026-$0.24-$0.07Beat 70.83%
Feb 12, 2026-$0.09-$0.14Miss -55.56%
Nov 13, 2025-$0.12-$0.15Miss -25.00%
Aug 12, 2025-$0.22-$0.21Beat 4.55%
Jun 23, 2025-$0.20-$0.21Miss -5.00%
Feb 13, 2025-$0.24-$0.26Miss -8.33%
Nov 13, 2024-$0.33-$0.33In line
Aug 9, 2024-$0.28-$0.24Beat 14.29%
Jun 21, 2024-$0.35-$0.18Beat 48.57%
Feb 12, 2024-$0.23-$0.24Miss -4.44%
Nov 13, 2023-$0.26-$0.32Miss -23.05%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026